Found 26 matching trials
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
PHASE2This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Location
Harbin Medical University Cancer Hospital
A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors
PHASE1This study is an open, multicenter Phase I/II clinical trial, divided into ...
Location
Zhejiang Cancer Hospital
A Study of SHR-A1811 in Subjects With Gynaecologic Oncology
PHASE2This is an open-label, two-part study to evaluate the safety and efficacy o...
Location
Qilu Hospital of Shandong University
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
PHASE3This study is a multicenter, randomized, open-label, parallel Phase III cli...
Status
Active Not Recruiting
Location
Shengjing Hospital, China Medical University
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
PHASE2The goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrel...
Location
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer
PHASE1This is an open-label, two-part study to evaluate the safety, tolerability,...
Location
Shanghai Chest Hospital
SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial
PHASE3The aim of this study was to evaluate whether the progression-free survival...
Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer
PHASE2This study is a single-arm, multicenter Phase II clinical trial of SHR-A181...
Location
Fujian Cancer Hospital
A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.
PHASE1The study is being conducted to evaluate the safety, tolerability, prelimin...
Location
The Second Hospital of Anhui Medical University
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
PHASE1This study is a multicentre, open-label, dose-finding/efficacy-expanding ph...
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences